Food & Drug Inspection Monitor

摘要

Human Drugs: Chemtura Corporation, Memphis, TN; Draxis Pharma, Kirkland, Quebec, Canada; Alza Corporation, Vacaville, CA; Positron Corporation, Houston, TX; Talon Acrylics, Portland, OR; Log; WASHINGTON — FDA by September will issue new guidance on how makers of OTC drags and dietary supplements will report adverse events under the new Dietary Supplement and Nonprescription Drug Consumer Protection Act (DS & NPD Act), industry learned Jan. 16 at a Drug Information Assn. (DIA) conference here.